Company: AEMD
Filing Date: 2025-06-26
Form Type: 10-K
Source: 0001683168-25-004780
Chunk: 502

Company: AETHLON MEDICAL INC
Filing Date: 2025-06-26
Form: 10-K
Item: Item 1C
Chunk 502
---
statements.

 F-5 

AETHLON MEDICAL, INC. AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE
LOSS

    Years Ended March 31, 

    2025  
    2024 

    OPERATING COSTS AND EXPENSES 

    Professional fees 
     2,224,092  
     3,526,926 
  
    Payroll and related expenses 
     3,874,092  
     5,206,451 
  
    General and administrative 
     3,243,181  
     3,903,191 
  
    Total operating expenses 
     9,341,365  
     12,636,568 

    OPERATING LOSS 
     (9,341,365) 
     (12,636,568)

    OTHER EXPENSE (INCOME), NET 

    Interest income 
     (298,122) 
     (447,356)
  
    Other income 
     (324,450) 
     – 
  
    Interest expense 
     10,109  
     – 
  
    Other expense 
     4,659,188  
     18,962 
  
    Total other expense (income), net 
     4,046,725  
     (428,394)

    NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS 
     (13,388,089) 
     (12,208,174)

    Basic and diluted net loss per share attributable to common stockholders 
    $(8.58) 
    $(38.87)

    Weighted average number of common shares outstanding - basic and diluted 
     1,560,839  
     314,097 

    NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS 
     (13,388,089) 
     (12,208,174)

    OTHER COMPREHENSIVE LOSS 
     (10,193) 
     (799)

    COMPREHENSIVE LOSS 
    $(13,398,282) 
    $(12,208,973)

See accompanying notes to the consolidated financial
statements.

 F-6 

AETHLON MEDICAL, INC. AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF EQUITY

FOR THE YEARS ENDED